<DOC>
	<DOCNO>NCT02655289</DOCNO>
	<brief_summary>Pain common symptom ( ca . 80 % patient ) German Palliative Care unit thus , pain control play central role palliative care . Transcutaneous electrical nerve stimulation ( TENS ) complementary treatment option patient experience suboptimal pain control . However , evidence efficacy TENS cancer patient unambiguous . The present study double blind , placebo-controlled cross-over trial short-term follow-up . The primary aim study evaluate efficacy safety TENS cancer pain reduction advance cancer patient . The secondary aim explorative identification subgroup benefit benefit TENS .</brief_summary>
	<brief_title>Transcutaneous Electrical Nerve Stimulation ( TENS ) Advanced Cancer Pain Patients</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Patients cancer pain ( caused tumor therapy ; associate tumor ) ≥ 3 11point NRS last 24 hour Age : ≥ 18 year Patients receive least 24 hour palliative care : palliative care ward , palliative care consultant service acute pain consultant service Verbal cognitive inability use TENS answer questionnaire High probability die within next week Pain directly indirectly relate tumor Contraindications : Jones ( 2009 ) &amp; Disselhoff ( 2012 ) electronic implant like pacemaker Metal implant electrode site Arrhythmia Pregnancy Epilepsy Dermatological condition frail skin electrode site Anamnestically know distinct allergy regard electrode Dropout criterion inclusion : Patients decide stop TENS treatment ( time reason ) . Further treatment indicate due rapid deterioration patient ' clinical status accord treat physician .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>